GALECTIN-3 LEVEL IN pATIENTS WITH mETAbOLIC SYNDROmE AND CORONARY HEART DISEASE

Aim. To assess the level of galectin-3  in blood serum  of patients  with metabolic syndrome  (MS), including comorbidity  with coronary  heart  disease (CHD), for evaluation of its significance as fibrosis marker in MS.Material and methods. Totally, 43 MS patients  studied  with CHD signs, and 33 p...

Full description

Saved in:
Bibliographic Details
Main Authors: O. М. Drapkina, R. N. Shepel, Т. A. Deeva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2017-03-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1594
Tags: Add Tag
No Tags, Be the first to tag this record!